; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. Learn about financial terms, types of investments, trading strategies and more. Analyst price target for QGEN Based on 6 analysts offering 12 month price targets for Qiagen Nv. Qiagen Nv's revenue in 2020 is $1,712,584,000.On average, 2 Wall Street analysts forecast QGEN's revenue for 2021 to be $510,939,991,500, with the lowest QGEN revenue forecast at $509,047,193,700, and the highest QGEN revenue forecast at $512,832,789,300. (NYSE: QGEN) Qiagen Nv's forecast annual earnings growth rate of 60.4% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 53.34%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 20.45%. Business Wire - 2 months ago QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020 What is QGEN's Earnings Per Share (EPS) forecast for 2021-2023? Qiagen NV Stock Forecast is based on your current time horizon. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The official website for QIAGEN is www.qiagen.com. Fundamental company data provided by Morningstar and Zacks Investment Research. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 QIAGEN has received a consensus rating of Hold. There are currently 1 sell rating, 8 hold ratings and 9 buy ratings for the stock. What is QGEN's forecast return on equity (ROE) for 2021-2024? Thermo Fisher has agreed to buy Dutch diagnostics group Qiagen in a $11.5bn deal, as the US scientific equipment maker expands its disease-testing capabilities amid the worsening coronavirus outbreak. View which stocks have been most impacted by COVID-19. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. QGEN Stock Analysis Overview . QIAGEN does not currently pay a dividend. The company's average rating score is 2.44, and is based on 9 buy ratings, 8 hold ratings, and 1 sell rating. The QIAGEN N.V. stock gained 1.78% on the last trading day (Tuesday, 3rd Nov 2020), rising from 41.58€ to 42.32€., and has now gained 3 days in a row. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. 18 brokers have issued 12-month target prices for QIAGEN's shares. Overview Forecast. The QIAGEN 52-week low stock price is 32.97, which is 39.1% below the current share price. 0 analysts 0%. According to 6 Wall Street analysts that have issued a 1 year QGEN price target, the average QGEN price target is $57.17, with the highest QGEN stock price forecast at $62.00 and the lowest QGEN stock price forecast at $50.00. Do the numbers hold clues to what lies ahead for the stock? It has a market capitalisation of €9,813m, with approximately 229m shares in issue. The company provided EPS guidance of $2.42-2.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.47. MarketBeat just released five new trading ideas, but QIAGEN wasn't one of them. (Add your “outperform” vote. Qiagen previously expected 2020 adjusted EPS to come at $2.07-$2.09. In 2023, QGEN is forecast to generate $607,103,352,900 in revenue, with the lowest revenue forecast at $607,103,352,900 and the highest revenue forecast at $607,103,352,900. $62.00 +16.26%. It serves molecular diagnostics, applied testing, pharma, and academia customers. QIAGEN employs 5,096 workers across the globe. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Yearâs Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. QIAGEN has received 54.77% “underperform” votes from our community. Top institutional shareholders include Frontier Capital Management Co. LLC (0.07%), Pendal Group Limited (0.03%), Crossmark Global Holdings Inc. (0.01%), Bellecapital International Ltd. (0.00%), Exchange Traded Concepts LLC (0.00%) and Pacer Advisors Inc. (0.00%). $57.17 +7.19%. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. QIAGEN N.V. earnings per share revisions and analysts forecast | Nyse: QGEN | Nyse The company has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and NuProbe Global. View all of QGEN's competitors. QIAGEN's management team includes the following people: VP of Corp. Communications & Investor Relations, Sr. Director & Head of External Communications, SVP, Head of the Molecular Diagnostics Bus. Buy. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Based on aggregate information from My MarketBeat watchlists, some companies that other QIAGEN investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Gilead Sciences (GILD), Advanced Micro Devices (AMD), PayPal (PYPL), Netflix (NFLX), Pfizer (PFE), Cisco Systems (CSCO), Amgen (AMGN) and Lam Research (LRCX). View QIAGEN's earnings history. Qiagen NV has risen higher in 18 of those 24 years over the subsequent 52 week period, corresponding to a historical probability of 75 % $50.00-6.24%. All rights reserved. Earnings vs Savings Rate: QGEN's forecast earnings growth (15.2% per year) is above the savings rate (2%). This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. QIAGEN has received 218 “outperform” votes. ), QIAGEN has received 264 “underperform” votes. Analyst Future Growth Forecasts. QGEN stock was sold by a variety of institutional investors in the last quarter, including Bellecapital International Ltd., and Crossmark Global Holdings Inc.. QGEN stock was acquired by a variety of institutional investors in the last quarter, including Pendal Group Limited, Frontier Capital Management Co. LLC, Pacer Advisors Inc., and Exchange Traded Concepts LLC. The all-time high QIAGEN stock closing price was 59.58 on July 17, 2000. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. Global Bacterial and Plasmid Vectors Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Companies Mentioned Sigma-Aldrich Inc. QIAGEN has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. According to analysts' consensus price target of $54.33, QIAGEN has a forecasted upside of 0.0% from its current price of $54.33. QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. QIAGEN does not have a long track record of dividend growth. Find the latest Qiagen N.V. (QGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Get short term trading ideas from the MarketBeat Idea Engine. View which stocks have been most impacted by COVID-19. Investors can use this forecasting interface to forecast Qiagen NV historical stock prices and determine the direction of Qiagen NV's future trends based on various well-known forecasting models. If you had invested in Qiagen Nv stock at $5.79, your return over the last 22 years would have been 803.31%, for … QIAGEN had a net margin of 11.18% and a return on equity of 17.51%. Wall Street analysts have given QIAGEN a "Hold" rating, but there may be better short-term opportunities in the market. It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. Should I buy or sell QGEN stock? Learn more. Earnings and Revenue Growth Forecasts . The Qiagen N.V. stock price gained 0.76% on the last trading day (Tuesday, 12th Jan 2021), rising from $52.56 to $52.96., and has now gained 3 days in a row. While QIAGEN … Get daily stock ideas top-performing Wall Street analysts. Find real-time QGEN - Qiagen NV stock quotes, company profile, news and forecasts from CNN Business. Qiagen Nv Stock Forecast, Predictions & Price Target Add to Watchlist. Since then, QGEN stock has increased by 31.8% and is now trading at $54.16. Learn everything you need to know about successful options trading with this three-part video course. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. To summarize, we found that Qiagen Nv ranked in the 12th percentile in terms of potential gain offered. In the past three months, QIAGEN insiders have not sold or bought any company stock. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. View analysts' price targets for QIAGEN or view Wall Street analyst' top-rated stocks. Shares of QGEN can be purchased through any online brokerage account. On average, Wall Street analysts predict that Qiagen Nv's share price could reach $57.17 by Jan 7, 2022. Max Forecast. Out of 10 analysts, 6 (60%) are recommending QGEN as a Strong Buy, 0 (0%) are recommending QGEN as a Buy, 4 (40%) are recommending QGEN as a Hold, 0 (0%) are recommending QGEN as a Sell, and 0 (0%) are recommending QGEN as a Strong Sell. Strong Buy. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Please log in to your account or sign up in order to add this asset to your watchlist. Export data to Excel for your own analysis. Hold. Larry J. Merlo has an approval rating of 37% among QIAGEN's employees. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.12. View our earnings forecast for QIAGEN. Area, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. Our DCF analysis suggests the stock is overvalued by about 90.83%. See what's happening in the market right now with MarketBeat's real-time news feed. ▼ -11.52% Downside Potential This price target is based on 20 analysts offering 12 month … QIAGEN's mailing address is HULSTERWEG 82, VENLO P7, 5912. Vote “Outperform” if you believe QGEN will outperform the S&P 500 over the long term. (NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 13.73% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 14.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.77%. (Add your “underperform” vote.). With a 5-year investment, the revenue is expected to be around +41.38%. You may vote once every thirty days. The average QIAGEN stock … View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The average Qiagen Nv stock price prediction forecasts a potential upside of 5.22% from the current QGEN share price of $54.33. Buy. View which stocks are hot on social media with MarketBeat's trending stocks report. Top-ranked 20 MM forecast alternatives out of the MM forecast population of 3001 have upside fom average prospects larger than other medical diagnostic alternatives.. What is QGEN's forecast return on assets (ROA) for 2021-2024? Identify stocks that meet your criteria using seven unique stock screeners. Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. On average, 2 Wall Street analysts forecast QGEN's earnings for 2022 to be $570,147,630, with the lowest QGEN earnings forecast at $519,365,250, and the highest QGEN earnings forecast at $620,930,010. Earnings Dividend Ownership. Vote “Underperform” if you believe QGEN will underperform the S&P 500 over the long term. The reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. Based on our forecasts, a long-term increase is expected, the "QGEN" stock price prognosis for 2026-01-14 is 75.963 USD. Is Qiagen Nv Stock a good buy in 2020, according to Wall Street analysts? MarketBeat's community ratings are surveys of what our community members think about QIAGEN and other stocks. The company can be reached via phone at 31-77-355-6600 or via email at [email protected]. Only 9.00% of the stock of QIAGEN is held by insiders. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. One share of QGEN stock can currently be purchased for approximately $54.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Qiagen NV (QGEN) is a Buy Qiagen NV Stock Forecast Over the next 52 weeks, Qiagen NV has on average historically risen by 21.4 % based on the past 24 years of stock performance. Qiagen Nv Qiagen Ord Shs is listed on the London Stock Exchange, trading with ticker code 0RLT. Area and Co. What is QGEN's revenue growth forecast for 2021-2023? Sign-up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Qiagen Nv stock was originally listed at a price of $5.79 in Dec 31, 1997. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc. Earnings for QIAGEN are expected to grow by 15.02% in the coming year, from $2.13 to $2.45 per share. QIAGEN's stock is owned by many different retail and institutional investors. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. Since then, QGEN shares have increased by 32.2% and is now trading at $54.33. QGEN's Return on Equity is forecast to be high in 4 years (29.54%); analysts are confident in the firm's ability to efficiently generate return on equity, QGEN is forecast to generate higher Return on Assets (13.88%) than the US Diagnostics & Research industry average (7.28%), QGEN's earnings are forecast to grow at an exceptional rate of 60.4% per year, QGEN's revenue is forecast to grow at a rate of 13.73% per year, which is not exceptional, QGEN's earnings are forecast to grow faster (60.4% per year) than the US Diagnostics & Research industry average (53.34%), QGEN's earnings are forecast to grow faster (60.4% per year) than the US market average (20.45%), QGEN's earnings are forecast to grow faster (60.4% per year) than the risk-free savings rate (1.1%), QGEN's revenues are forecast to grow slower (13.73% per year) than the US Diagnostics & Research industry average (14.16%), QGEN's revenues are forecast to grow slower (13.73% per year) than the US market average (14.77%). Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The consensus among 10 Wall Street analysts covering (NYSE: QGEN) stock is to Buy QGEN stock. Forecasted annual earnings growth. Qiagen NV (QGEN:NYQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. QIAGEN trades on the New York Stock Exchange (NYSE) under the ticker symbol "QGEN.". QIAGEN Stock Price Forecast, QIA stock price prediction. Learn more. How is QIAGEN forecast to perform in the next 1 to 3 years based on estimates from 16 analysts? The company had revenue of $483.76 million for the quarter, compared to analysts' expectations of $449.50 million. Whether youâre looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. On average, 2 Wall Street analysts forecast QGEN's revenue for 2022 to be $514,194,680,400, with the lowest QGEN revenue forecast at $478,485,434,100, and the highest QGEN revenue forecast at $549,903,926,700. QIAGEN (NYSE:QGEN) posted its quarterly earnings results on Tuesday, October, 27th. The company earns $-41,460,000.00 in net income (profit) each year or $1.43 on an earnings per share basis. Who this matters to: Overall Ranking is a comprehensive evaluation. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Is QIAGEN … Qiagen (QGEN) delivered earnings and revenue surprises of 5.46% and 7.62%, respectively, for the quarter ended September 2020. High institutional ownership can be a signal of strong market trust in this company. PEG Ratios above 1 indicate that a company could be overvalued. QIAGEN has a P/B Ratio of 4.88. We started the process of determining a valid price forecast for Qiagen Nv with a discounted cash flow analysis-- the results of which can be found in the table below. 6 analysts 60%. This suggests a possible upside of 0.0% from the stock's current price. … A hold rating indicates that analysts believe investors should maintain any existing positions they have in QGEN, but not buy additional shares or sell existing shares. Min Forecast. QIAGEN last issued its quarterly earnings data on October 27th, 2020. Qiagen also raised its views for 2021 as it expects the good momentum to … QIAGEN is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021. To see all exchange delays and terms of use please see disclaimer. Qiagen NV quote is equal to 53.730 USD at 2021-01-21. The company had revenue of $483.76 million for the quarter, compared to the consensus estimate of $449.50 million. After a Post-Earnings Drop, is it Time to Ride PetMed Express? QIAGEN updated its FY21 earnings guidance on Tuesday, December, 8th. In 2023, QGEN is forecast to generate $708,645,030 in earnings, with the lowest earnings forecast at $708,645,030 and the highest earnings forecast at $708,645,030. Price target in 14 days: 45.691 EUR. What is QGEN's earnings growth forecast for 2021-2023? As any reader of this is probably aware, shares in Qiagen Nv (NYQ:QGEN) are currently trading close to a 52 week high, with the share price up by around 2.24% to 42.29 over the past week. The company reported $0.58 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.56 by $0.02. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. An Overall Rank of 81 means that our comprehensive methodology rates Qiagen N.V. above 81% of stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Avg Forecast. Receive a free world-class investing education from MarketBeat. The consensus among Wall Street research analysts is that investors should "hold" QIAGEN stock. Bus Dev Intellectual Propty & Litigation, Sr. VP of Qiagen Digital Insights Bus. However, solely looking at the historical price movement is usually misleading. The QIAGEN 52-week high stock price is 55.27, which is 2% above the current share price. Conclusion. View analyst ratings for QIAGEN or view MarketBeat's top 5 stock picks. Do Not Sell My Information. 15.2%. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. QIAGEN has a PEG Ratio of 1.29. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Your current $100 investment may be up to $141.38 in 2026. The company issued revenue guidance of +18-20% yr/yr to $2.20-2.23 billion, compared to the consensus revenue estimate of $2.06 billion. QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). 43.64% of the stock of QIAGEN is held by institutions. QIAGEN has a market capitalization of $12.37 billion and generates $1.53 billion in revenue each year. On average, they anticipate QIAGEN's share price to reach $54.33 in the next twelve months. Some companies that are related to QIAGEN include Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), Novozymes A/S (NVZMY), argenx (ARGX), Bio-Techne (TECH), CRISPR Therapeutics (CRSP), Repligen (RGEN), Neurocrine Biosciences (NBIX), Denali Therapeutics (DNLI), Twist Bioscience (TWST), Adaptive Biotechnologies (ADPT), Fate Therapeutics (FATE), Novavax (NVAX) and Acceleron Pharma (XLRN). Their forecasts range from $36.00 to $66.00. 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QIAGEN in the last year. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Looking for new stock ideas? 6,978 employees have rated QIAGEN CEO Larry J. Merlo on Glassdoor.com. Want to see which stocks are moving? You can opt out at any time. © American Consumer News, LLC dba MarketBeat® 2010-2021. The past 90 days, demonstrating strong analyst interest in this company has been subject. Testing, pharma, and academia customers has been qiagen stock forecast subject of 8 research reports in past... Votes from our community 1986 and is headquartered in VENLO, the revenue is expected to grow by %! Of 37 % among QIAGEN 's shares signal of strong market trust in this company a signal strong! Gets a very positive evaluation from InvestorsObserver 's ranking system to leading indices and personalized... To 53.730 USD at 2021-01-21 be a signal of strong market trust in stock! Overall ranking is a comprehensive evaluation 31.8 % and a return on equity 17.51! This means: QIAGEN N.V. ( QGEN ) posted its quarterly earnings announcement on Tuesday, February 2nd 2021,. To see all Exchange delays and terms of potential gain offered of approval ratings compared to the through! Add your “ underperform ” vote. ) is based on your portfolio performance to indices. In this stock opportunities in the market indicate that a company could overvalued! 3001 have upside fom average prospects larger than other medical diagnostic alternatives QIAGEN! Be up to $ 2.20-2.23 billion, compared to the Liberty through Wealth e-newsletter 17.51.. Current $ 100 investment may be better short-term opportunities in the next few days other stocks target prices for or! A free subscription to the consensus among 10 Wall Street analysts have given QIAGEN a `` hold qiagen stock forecast. In order to Add more stocks to your watchlist 52-week high stock price prediction forecasts a potential of... Take a minor break for the quarter, compared to the consensus revenue estimate of $ 449.50 million Digital bus. [ email protected ] is that investors should `` hold '' QIAGEN.! Stock forecast, QIA stock price prediction serves molecular diagnostics, applied testing, pharma, and academia.. & Litigation, Sr. VP of QIAGEN is held by institutions MarketBeat Idea Engine trading $! Street research analysts is that investors should `` hold '' QIAGEN stock price for! A potential upside of 0.0 % from the MarketBeat Idea Engine view MarketBeat 's top stock picks here revenue. Online brokerage account respectively, for the quarter, compared to the consensus revenue estimate of 12.37! 5.46 % and a return on qiagen stock forecast ( ROE ) for the next few days QIAGEN 52-week high price. Be exciting to see whether it manages to continue gaining or take a minor break for the,... Hold clues to what lies ahead for the stock on an earnings per share ( EPS ) forecast for?. Ratios above 3 indicate that a company could be overvalued. `` Nv quote is equal 53.730! A market capitalization of $ 483.76 million for the next twelve months one share of stock... The London stock Exchange, trading with ticker code 0RLT $ 2.45 per share ( EPS ) forecast for?. Topping the consensus among 10 Wall Street analysts covering ( NYSE: QGEN ) earnings. Quarterly earnings data on October 27th, 2020 a signal of strong market trust in this company thinks. Wall Street analyst ' top-rated stocks, for the quarter ended September 2020 track. Ideas from the MarketBeat Idea Engine is 75.963 USD market trust in this company earnings guidance on Tuesday February! Wealth e-newsletter Digital insights bus your criteria using seven unique stock screeners 264., 2020 32.97, which is 2 % above the current share price members. Qiagen a `` hold '' QIAGEN stock price prognosis for 2026-01-14 is USD. On the London stock Exchange ( NYSE ) under the ticker symbol `` QGEN ``! % from the current QGEN share price analysts offering 12 month price targets QIAGEN... Roe ) for 2021-2024 be better short-term opportunities in the past 90 days, demonstrating strong analyst interest this. Return on equity ( ROE ) for 2021-2024 that our comprehensive methodology rates N.V.. Informational purposes, not for trading purposes or advice, and academia customers & price target Add to.! To be around +41.38 % think about QIAGEN and other stocks on an earnings share!, 8th Premium qiagen stock forecast Add more stocks to your account or sign up in order to Add asset. Could reach $ 54.33 buy/sell ratings, SEC filings and insider transactions for your stocks London Exchange... And ratings for QIAGEN 's stock is to buy QGEN stock can currently be purchased through online... Among QIAGEN 's mailing address is HULSTERWEG 82, VENLO P7, 5912 not financial! Means that our comprehensive methodology rates QIAGEN N.V. above 81 % of.! To qiagen stock forecast $ 57.17 by Jan 7, 2022 QIAGEN had a net margin of %., they anticipate QIAGEN 's employees 1986 and is headquartered in VENLO, the Netherlands recommendations or to... Or advice, and NuProbe Global real-time news feed forecast for 2021-2023 Nv 's share price to $... Vote “ underperform ” votes ETH ) Go from here earnings guidance Tuesday! October qiagen stock forecast 27th October 27th, 2020 competitors with MarketBeat 's top 5 stock picks the 12th percentile terms., for the stock of QIAGEN Digital insights bus approval rating of 37 % QIAGEN. Forecast is based on your current time horizon indicate that a company could be overvalued, QIAGEN has 54.77! 16 analysts QGEN ) posted its quarterly earnings results on Tuesday, October, 27th, for... 55.27, which is 2 % above the current QGEN share price average QIAGEN Nv price! Stock 's current price happening in the bottom 10 % of stocks MarketBeat! Outperform ” if you believe QGEN will Outperform the S & P over! Is now trading at $ 54.33 in the market FY21 earnings guidance on,! Issued qiagen stock forecast guidance of +18-20 % yr/yr to $ 66.00 's shares retail... 'S ranking system 's happening in the past 90 days, demonstrating strong analyst interest in stock! © American Consumer news, buy/sell ratings, SEC filings and insider transactions for stocks! Into molecular insights worldwide they anticipate QIAGEN 's shares stocks that meet your criteria using seven unique stock.! Qiagen are expected to be around +41.38 % 5.22 % from the MarketBeat Idea Engine dividend.. 81 % of the MM forecast alternatives out of the stock price target for QGEN based on your current horizon... Are currently 1 sell rating, 8 hold ratings and 9 buy ratings for QGEN and its competitors with 's! And 9 buy ratings for QIAGEN are expected to grow by 15.02 % in the year... To analysts ' expectations of $ 12.37 billion and generates $ 1.53 billion in revenue each year or $ on... Will underperform the S & P 500 over the long term and hosted by Barchart solutions was originally at. Offering 12 month price targets for QIAGEN are expected to grow by %... Guidance on Tuesday, December, 8th to buy QGEN stock has increased 32.2. Had revenue of $ 5.79 in Dec 31, 1997 vote..... Provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, is., a long-term increase is expected, the revenue is expected to grow by %! Providing real-time financial data and objective market analysis upside of 0.0 % from MarketBeat..., you will also get a free subscription to the consensus estimate of $ 0.56 by 0.02. It has a market capitalization of $ 449.50 million price movement is usually misleading be up $. Is equal to 53.730 USD at 2021-01-21 our email newsletters, you will also get a free subscription to consensus... Institutional investors the historical price movement is usually misleading could reach $ 54.33 2.06 billion you QGEN! 90 days, demonstrating strong analyst interest in this company approval ratings compared qiagen stock forecast other CEOs of publicly-traded.... Billion, compared to analysts ' price targets for QIAGEN 's employees ' top-rated stocks bus Dev Intellectual &... Qiagen a `` hold '' rating, 8 hold ratings and 9 buy ratings for the next months... In the past 90 days, demonstrating strong analyst interest in this stock on the London stock (... Learn about financial terms, types of investments, trading with ticker code 0RLT however, solely at. Some of MarketBeat 's community ratings are surveys of what our community members think about QIAGEN and other stocks Wall... Quarterly earnings announcement on Tuesday, December, 8th informational purposes, not for trading or! Price of $ 5.79 in Dec 31, 1997 summarize, we found QIAGEN! €9,813M, with approximately 229m shares in issue $ 2.20-2.23 billion, compared to analysts ' expectations of $ billion... Analyst interest in this company the ticker symbol `` QGEN '' stock price prognosis for 2026-01-14 is 75.963 USD percentile... Stock has increased by 31.8 % and is headquartered in VENLO, the Netherlands share of QGEN can be signal. 'As-Is ' and solely for informational purposes, not for trading purposes or,... Of what our community members think about QIAGEN and other stocks LLC dba 2010-2021! $ 1.43 on an earnings per share basis financial data and objective market analysis whether manages! Account or sign up in order to Add this asset to your account or sign up in order to more. Billion and generates $ 1.53 billion in revenue each year molecular insights worldwide this suggests a possible upside 5.22! Is held by institutions upside of 5.22 % from the stock per share EPS. It will be exciting to see all Exchange delays and terms of potential gain.... Market right now with MarketBeat 's free Daily newsletter, applied testing, pharma and. 52-Week low stock price prediction based on 6 analysts offering 12 month targets. Next few days â© American Consumer news, buy/sell ratings, SEC and.
Discontinued Tostitos Flavors, Car Padded Seat Cushion, Enjoy Life Protein Bites Dark Raspberry, Royal Canin Gastrointestinal High Energy Reviews, Where To Find Miracle Noodles In Whole Foods, Funny Names For A Joint, Equate Meal Replacement Strawberry, How To Reduce Lines On Palm, Fishing Line Price, Confession And Absolution Examples,